mibefradil has been researched along with Diabetic Nephropathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allen, TJ; Cao, Z; Cooper, ME; Ma, G | 1 |
1 other study(ies) available for mibefradil and Diabetic Nephropathies
| Article | Year |
|---|---|
Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes.
Topics: Albuminuria; Amlodipine; Animals; Azo Compounds; Blood Pressure; Calcium Channel Blockers; Collagen Type I; Coloring Agents; Diabetic Nephropathies; Fibronectins; Gene Expression; Kidney; Male; Mibefradil; Organ Size; Rats; Rats, Sprague-Dawley | 2004 |